|
2006 Journal Article Epstein-Barr virus and advanced chronic lymphocytic leukemia: innocent until proven guilty? Commentary on: Tsimberidou et al. Epstein-Barr virus in patients with chronic lymphocytic leukemia: A pilot study. Leuk Lymphoma 2006; 47 : 827-836Gandhi, M and Khanna, R (2006). Epstein-Barr virus and advanced chronic lymphocytic leukemia: innocent until proven guilty? Commentary on: Tsimberidou et al. Epstein-Barr virus in patients with chronic lymphocytic leukemia: A pilot study. Leuk Lymphoma 2006; 47 : 827-836. Leukemia & Lymphoma, 47 (5), 779-780. doi: 10.1080/10428190600580973 |
|
2006 Journal Article Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8(+) T-cell function in Hodgkin lymphoma patientsGandhi, M. K., Lambley, E., Duraiswamy, J., Dua, U., Smith, C., Elliott, S., Gill, D., Marlton, P., Seymour, J. and Khanna, R. (2006). Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8(+) T-cell function in Hodgkin lymphoma patients. Blood, 108 (7), 2280-2289. doi: 10.1182/blood-2006-04-015164 |
|
2006 Journal Article Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphomaGandhi, M. K., Lambley, E., Burrows, J., Dua, U., Elliott, S., Shaw, P. J., Prince, H. M., Wolf, M., Clarke, K., Underhill, C., Mills, T., Mollee, P., Gill, D., Marlton, P., Seymour, J. F. and Khanna, R. (2006). Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma. Clinical Cancer Research, 12 (2), 460-464. doi: 10.1158/1078-0432.CCR-05-2008 |
|
2006 Journal Article Correlation of T-cell immune response with spontaneous resolution and subsequent relapse of Hodgkin's lymphomaWilson, W. M., Dua, U., Grigg, A. P. and Gandhi, M. K. (2006). Correlation of T-cell immune response with spontaneous resolution and subsequent relapse of Hodgkin's lymphoma. Leukemia & Lymphoma, 47 (5), 871-876. doi: 10.1080/10428190600649562 |
|
2006 Journal Article Epstein-Barr virus-associated lymphomasGandhi, M. K. (2006). Epstein-Barr virus-associated lymphomas. Expert Review of Anti-Infective Therapy, 4 (1), 77-89. doi: 10.1586/14737140.4.1.77 |
|
2005 Journal Article Viruses and lymphomaGandhi, Maher K. and Khanna, Rajiv (2005). Viruses and lymphoma. Pathology, 37 (6), 420-433. doi: 10.1080/003130200500368303 |
|
2005 Journal Article Follicular lymphoma: Time for a re-think?Gandhi, Maher K. and Marcus, Robert E. (2005). Follicular lymphoma: Time for a re-think?. Blood Reviews, 19 (3), 165-178. doi: 10.1016/j.blre.2004.09.001 |
|
2005 Journal Article Regulation of clinical researchGandhi, Maher K. (2005). Regulation of clinical research. Clinical Medicine, 5 (3), 299-299. doi: 10.7861/clinmedicine.5-3-299 |
|
2005 Journal Article Technology Insight: Applications of emerging immunotherapeutic strategies for Epstein-Barr virus-associated malignanciesKhanna, Rajiv, Moss, Denis and Gandhi, Maher (2005). Technology Insight: Applications of emerging immunotherapeutic strategies for Epstein-Barr virus-associated malignancies. Nature Clinical Practice Oncology, 2 (3), 138-149. doi: 10.1038/ncponc0107 |
|
2004 Journal Article Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatmentsGandhi, Maher K. and Khanna, Rajiv (2004). Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infectious Diseases, 4 (12), 725-738. doi: 10.1016/S1473-3099(04)01202-2 |
|
2004 Journal Article Epstein-Barr virus-associated Hodgkin's lymphomaGandhi, Maher K., Tellam, Judy T. and Khanna, Rajiv (2004). Epstein-Barr virus-associated Hodgkin's lymphoma. British Journal of Haematology, 125 (3), 267-281. doi: 10.1111/j.1365-2141.2004.04902.x |
|
2003 Journal Article Human cytomegalovirus-specific immunity following haemopoietic stem cell transplantationGandhi, MK, Wills, MR, Sissons, JGP and Carmichael, AJ (2003). Human cytomegalovirus-specific immunity following haemopoietic stem cell transplantation. Blood Reviews, 17 (4), 259-264. doi: 10.1016/S0268-960X(03)00028-6 |
|
2003 Journal Article Late diversification in the clonal composition of human cytomegalovirus-specific CD8(+) T cells following allogeneic hemopoietic stem cell transplantationGandhi, MK, Wills, MR, Okecha, G, Day, EK, Hicks, R, Marcus, RE, Sissons, JGP and Carmichael, AJ (2003). Late diversification in the clonal composition of human cytomegalovirus-specific CD8(+) T cells following allogeneic hemopoietic stem cell transplantation. Blood, 102 (9), 3427-3438. doi: 10.1182/blood-200-12-3689 |
|
2003 Journal Article Significant and persistent loss of bone mineral density in the femoral neck after haematopoietic stem cell transplantation: long-term follow-up of a prospective studyGandhi, MK, Lekamwasam, S, Inman, I, Kaptoge, S, Sizer, L, Love, S, Bearcroft, PW, Milligan, TP, Price, CP, Marcus, RE and Compston, JE (2003). Significant and persistent loss of bone mineral density in the femoral neck after haematopoietic stem cell transplantation: long-term follow-up of a prospective study. British Journal of Haematology, 121 (3), 462-468. doi: 10.1046/j.1365-2141.2003.04303.x |
|
2002 Journal Article Identification of naive or antigen-experienced human CD8(+) T cells by expression of costimulation and chemokine receptors: Analysis of the human cytomegalovirus-specific CD8(+) T cell responseWills, MR, Okecha, G, Weekes, MP, Gandhi, MK, Sissons, PJG and Carmichael, AJ (2002). Identification of naive or antigen-experienced human CD8(+) T cells by expression of costimulation and chemokine receptors: Analysis of the human cytomegalovirus-specific CD8(+) T cell response. Journal of Immunology, 168 (11), 5455-5464. doi: 10.4049/jimmunol.168.11.5455 |
|
2001 Journal Article Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipientsGandhi, MK, Egner, W, Sizer, L, Inman, I, Zambon, M, Craig, JIO and Marcus, RE (2001). Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients. Bone Marrow Transplantation, 28 (8), 775-781. doi: 10.1038/sj.bmt.1703239 |
|
2000 Journal Article A comparison of molecular and enzyme-based assays for the detection of thiopurine methyltransferase mutationsCoulthard, SA, Rabello, C, Robson, J, Howell, C, Minto, L, Middleton, PG, Gandhi, MK, Jackson, G, McLelland, J, O'Brien, H, Smith, S, Reid, MM, Pearson, ADJ and Hall, AG (2000). A comparison of molecular and enzyme-based assays for the detection of thiopurine methyltransferase mutations. British Journal of Haematology, 110 (3), 599-604. doi: 10.1046/j.1365-2141.2000.02218.x |
|
2000 Journal Article Status of Cytomegalovirus prevention and treatment in 2000Zaia, John A., Sissons, J. G. Patrick, Riddell, Stanley, Diamond, Don J., Wills, M. R., Carmichael, A. J., Weekes, M. P., Gandhi, M., La Rosa, C., Villacres, M., Lacey, S., Markel, S. and Sun, J. (2000). Status of Cytomegalovirus prevention and treatment in 2000. Hematology, 339-355. doi: 10.1182/asheducation-2000.1.339 |
|
1999 Journal Article A comparison of CD34(+) cell selected and unselected autologous peripheral blood stem cell transplantation for multiple myeloma: a case controlled analysisGandhi, MK, Jestice, HK, Scott, MA, Bloxham, DM, Bass, G, Craig, JIO and Marcus, RE (1999). A comparison of CD34(+) cell selected and unselected autologous peripheral blood stem cell transplantation for multiple myeloma: a case controlled analysis. Bone Marrow Transplantation, 24 (4), 369-375. doi: 10.1038/sj.bmt.1701938 |
|
1999 Journal Article The minimum CD34 threshold depends on prior chemotherapy in autologous peripheral blood stem cell recipientsGandhi, MK, Jestice, K, Scott, MA, Bloxham, D, Bass, G and Marcus, RE (1999). The minimum CD34 threshold depends on prior chemotherapy in autologous peripheral blood stem cell recipients. Bone Marrow Transplantation, 23 (1), 9-13. doi: 10.1038/sj.bmt.1701530 |
